Weekly round up from Life Sciences Industry.
Varian (NYSE: VAR) announced it has successfully completed its asset purchase of the Boston Scientific portfolio of microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. This acquisition expands the portfolio of Varian interventional oncology solutions.
Date: August 26, 2019
Source: Varian
Sign up for DistilINFO e-Newsletters.
Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies
Vynca and Intermountain Healthcare Partner to Prioritize and Digitize Advance Care Planning
Accounting for the Social Determinants of Health During the COVID-19 Pandemic
Talkspace, Bicycle Health Partner to Expand Therapeutic Offerings
Cleveland Clinic Makes COVID-19 Risk Prediction Model Available Through Epic
Henry Schein To Expand Its Medical Group With Acquisition Of North American Rescue
Women’s Health Platform Maven Clinic Scores $90M in Funding
Choom Signs Definitive Agreement to Acquire Clarity Cannabis Retail Stores in Alberta